Medtronic PLC MDT

88.64 0.13 0.15% as of 25 Sep
Market cap
$112.2B
P/E
21.7×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Medtronic PLC (MDT) Price to free cash flow

As of 25 September 2026, Medtronic PLC (MDT) trades at a price to free cash flow of 18.5×. Over the past ten years it has ranged from 12.5× (January 2015) to 38.2× (April 2021); the current reading is higher than 10% of that period. That is below the Medical Devices industry median of 22.5× and below the Healthcare sector median of 19.5×.

Price to free cash flow, daily

Annual

Period Price to free cash flow Change
FY2026 19.1× (8.98%)
FY2025 21.0× 2.58%
FY2024 20.5× (22.19%)
FY2023 26.3× 13.68%
FY2022 23.2× (35.74%)
FY2021 36.0× 65.80%
FY2020 21.7× 6.78%
FY2019 20.4× (32.28%)
FY2018 30.1× 46.48%
FY2017 20.5× (23.45%)

Quarterly

Period Price to free cash flow Change
Jul 2026 17.8× (6.83%)
Apr 2026 19.1× (21.45%)
Jan 2026 24.4× 9.02%
Oct 2025 22.3× 2.41%
43 more quarters

Against its own ten years

Low 12.5× High 38.2×
Ten-year median 23.0×
Current reading's percentile 10

Price to free cash flow against peers

Company Price to free cash flow
PHG Koninklijke Philips N.V. compare 12.9×
BSX Boston Scientific Corporation compare 17.8×
MDT Medtronic PLC 18.5×
GEHC GE HealthCare Technologies Inc. compare 19.1×
STE STERIS plc compare 21.8×
SYK Stryker Corporation compare 22.2×
ABT Abbott Laboratories compare 22.5×
DXCM DexCom, Inc. compare 23.6×
EW Edwards Lifesciences Corporation compare 35.4×
Medical Devices industry median 22.5×
Healthcare sector median 19.5×
Market median 14.0×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on MDT